The studies in the kidney, demonstrate that KLF5 modulates kidney diseases by regulating a variety of cellular responses including apoptotic cell death, inflammation, cell proliferation and fibrosis, making KLF5 a plausible therapeutic drug target to treat kidney diseases. Here, KLF5 is linked to kidney disorder.